Ultragenyx Pharmaceutical
RARE
#3656
Rank
HK$27.25 B
Marketcap
HK$282.45
Share price
-0.41%
Change (1 day)
-26.33%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$27.25 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of HK$27.25 Billion. This makes Ultragenyx Pharmaceutical the world's 3656th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$27.25 B-12.46%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$27.25 Billion
by Nasdaq info icon info icon
HK$27.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$80.33 B 194.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$23.55 B-13.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.99 B-74.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$3.70 B-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA